236.97

0.93% 2.18

After Hours: 236.97

Iqvia Holdings Inc (IQV)

Overview News Price History Option Chain Financials Discussions Forecast

Iqvia Holdings Inc stock is traded at $236.97, with a volume of 705.78K. It is up +0.93% in the last 24 hours and down -5.80% over the past month. IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Previous Close:

$234.79

Open:

$233.61

24h Volume:

705.78K

Relative Volume:

0.61

Market Cap:

$42.69B

Revenue:

$15.16B

Net Income/Loss:

$1.42B

P/E Ratio:

39.83

EPS:

5.95

Net Cash Flow:

$1.83B

1W Performance:

-1.56%

1M Performance:

-5.80%

6M Performance:

-6.30%

1Y Performance:

+20.44%

1-Day Range:

$233.61

$237.30

1-Week Range:

$230.00

$241.88

52-Week Range:

$167.42

$261.73

Iqvia Holdings Inc Stock (IQV) Company Profile

Name

Iqvia Holdings Inc

Sector

Healthcare (1190)

Industry

Diagnostics & Research (58)

Phone

919-998-2000

Address

2400 ELLIS ROAD, DURHAM, NC

Employee

88,000

Twitter

@IQVIA_global

Next Earnings Date

2024-10-30

Latest SEC Filings

IQV's Discussions on Twitter

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Feb-13-24	Initiated	BTIG Research	Buy
Nov-02-23	Downgrade	Robert W. Baird	Outperform → Neutral
Sep-06-23	Initiated	HSBC Securities	Buy
Mar-17-23	Initiated	Truist	Buy
Dec-06-22	Initiated	Cowen	Outperform
Nov-17-22	Downgrade	Citigroup	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Jul-15-22	Initiated	SVB Leerink	Outperform
May-24-22	Initiated	Guggenheim	Buy
Apr-29-22	Upgrade	Piper Sandler	Neutral → Overweight
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Aug-05-21	Resumed	Credit Suisse	Outperform
Apr-16-21	Upgrade	Stephens	Equal-Weight → Overweight
Mar-08-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-03-21	Initiated	Barclays	Overweight
Jul-07-20	Initiated	Stephens	Equal-Weight
Mar-02-20	Initiated	Deutsche Bank	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Dec-13-19	Upgrade	CFRA	Sell → Hold
Nov-14-19	Upgrade	Wolfe Research	Peer Perform → Outperform
Jun-21-19	Upgrade	Mizuho	Neutral → Buy
May-28-19	Initiated	SVB Leerink	Outperform
Jan-18-19	Upgrade	Jefferies	Hold → Buy
Oct-09-18	Initiated	UBS	Buy
Oct-02-18	Reiterated	Robert W. Baird	Outperform
Jul-25-18	Upgrade	BofA/Merrill	Neutral → Buy
Jul-25-18	Reiterated	Stifel	Buy
Jul-03-18	Upgrade	Raymond James	Outperform → Strong Buy
Apr-13-18	Upgrade	Goldman	Neutral → Buy
Mar-07-18	Upgrade	SunTrust	Hold → Buy
Jan-19-18	Initiated	Evercore ISI	Outperform

View All

Iqvia Holdings Inc Stock (IQV) Latest News

04:57 AM

IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

04:57 AM

11:35 AM

New 4-Star Stocks - Morningstar

11:35 AM

07:00 AM

Possible Bearish Signals With IQVIA Holdings Insiders Disposing Stock - Yahoo Finance

07:00 AM

05:19 AM

Mackenzie Financial Corp Has $19.57 Million Stake in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

05:19 AM

Sep 29, 2024

MBB Public Markets I LLC Takes Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Sep 29, 2024

Sep 28, 2024

Marshall Wace LLP Purchases 65,974 Shares of IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Sep 28, 2024

StockNews.com Downgrades IQVIA (NYSE:IQV) to Hold - MarketBeat

Sep 28, 2024

Sep 26, 2024

Sei Investments Co. Buys 24,363 Shares of IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat

Sep 26, 2024

Sep 25, 2024